Strategies for the Design of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Lessons from the Development of Seven Representative Paradigms

被引:118
作者
Li, Dongyue [1 ]
Zhan, Peng [1 ]
De Clercq, Erik [2 ]
Liu, Xinyong [1 ]
机构
[1] Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Jinan 250012, Shandong, Peoples R China
[2] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
基金
中国国家自然科学基金; 中国博士后科学基金; 高等学校博士学科点专项科研基金;
关键词
RESISTANT MUTANT VIRUSES; MEDICINAL CHEMISTRY; DRUG CANDIDATES; MOLECULAR HYBRIDIZATION; ANGSTROM RESOLUTION; ANTIVIRAL ACTIVITY; ETRAVIRINE TMC125; BROAD POTENCY; DAPY ANALOGS; WILD-TYPE;
D O I
10.1021/jm200990c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:3595 / 3613
页数:19
相关论文
共 80 条
  • [1] Halogen bonds in biological molecules
    Auffinger, P
    Hays, FA
    Westhof, E
    Ho, PS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (48) : 16789 - 16794
  • [2] BONNEAU PR, 2004, 11 C RETR OPP INF SA
  • [3] Brotherton-Pleiss CE, 2008, [No title captured], Patent No. [WO 2008071587, 2008071587]
  • [4] On scaffolds and hopping in medicinal chemistry
    Brown, Nathan
    Jacoby, Edgar
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (11) : 1217 - 1229
  • [5] Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1
    Chan, JH
    Freeman, GA
    Tidwell, JH
    Romines, KR
    Schaller, LT
    Cowan, JR
    Gonzales, SS
    Lowell, GS
    Andrews, CW
    Reynolds, DJ
    St Clair, M
    Hazen, RJ
    Ferris, RG
    Creech, KL
    Roberts, GB
    Short, SA
    Weaver, K
    Koszalka, GW
    Boone, LR
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (05) : 1175 - 1182
  • [6] New uses for old drugs
    Chong, Curtis R.
    Sullivan, David J., Jr.
    [J]. NATURE, 2007, 448 (7154) : 645 - 646
  • [7] Recent developments in fragment-based drug discovery
    Congreve, Miles
    Chessari, Gianni
    Tisi, Dominic
    Woodhead, Andrew J.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) : 3661 - 3680
  • [8] Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants
    Das, K
    Clark, AD
    Lewi, PJ
    Heeres, J
    de Jonge, MR
    Koymans, LMH
    Vinkers, HM
    Daeyaert, F
    Ludovici, DW
    Kukla, MJ
    De Corte, B
    Kavash, RW
    Ho, CY
    Ye, H
    Lichtenstein, MA
    Andries, K
    Pauwels, R
    de Béthune, MP
    Boyer, PL
    Clark, P
    Hughes, SH
    Janssen, PAJ
    Arnold, E
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) : 2550 - 2560
  • [9] From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125):: Fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase
    De Corte, BL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 1689 - 1696
  • [10] Tri-substituted triazoles as potent non-nucleoside inhibitors of the HIV-1 reverse transcriptase
    De La Rosa, Martha
    Kim, Hong Woo
    Gunic, Esmir
    Jenket, Cheryl
    Boyle, Uyen
    Koh, Yung-hyo
    Korboukh, Ilia
    Allan, Matthew
    Zhang, Weijian
    Chen, Huanming
    Xu, Wen
    Nilar, Shahul
    Yao, Nanhua
    Hamatake, Robert
    Lang, Stanley A.
    Hong, Zhi
    Zhang, Zhijun
    Girardet, Jean-Luc
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (17) : 4444 - 4449